I agree with the comment from the end of page 3 of this thread...

I agree with the comment from the end of page 3 of this thread in December last year:

It went up too far too quickly, news flow stopped, directors offloaded, Florida wasn't the blockbuster hoped for.

i would add that there has been zero new announcements of substance in 2020, projections confirmed (and then withdrawn), a cap raise and directors selling. The downside to heavy reliance on China as a client vastly outweighs the benefits in circumstances where China/Australia relations are in the freezer.

The share price reflects board and company performance.

There is no compelling reason to buy PET absent positive news and I couldn’t rule out a fall below $0.20.